Sign up to save your podcasts
Or
Share Robust Knowledge Management Activities in Process Validation to Ensure Intrinsic Compliance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Robust Knowledge Management Activities in Process Validation to Ensure Intrinsic Compliance
In this episode, Stacey and Cliff speak about new ways of thinking across the industry that aim to ensure appropriate, risk-based, least burdensome validation, with a focus of validation activities, instead of the traditional “are we compliant” mentality.
For more information on this topic:
ICH Q10 Feedforward, https://www.fda.gov/media/71553/download
- Process Validation Systems Based Inspection, https://www.fda.gov/files/drugs/published/Process-Validation--General-Principles-and-Practices.pdf
Cliff is a highly experienced consultant with a proven track record in efficient, agile and flexible compliance. His strengths include validation strategy, process mapping and gap analysis projects, both short and long term. He is exceptionally well regarded, and has worked collaboratively and co-authored with regulatory agencies, such as the FDA and HPRA, providing leadership training and advisory services. In addition to FDA, projects and workshops have been successfully completed for the following companies: Aveo, Amgen, Bayer, BioMarin, Celgene, Janssen, Kite, Lonza, Novartis, Parexel, Pfizer, Prolong. Cliff is also a long time contributor to the IVT Network, publishing articles in the Journal of Validation
Technology since 2010. Cliff was awarded the Kenneth G. Chapman Award in 2017 in recognition for his long standing efforts and contributions to validation.
Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.
View all episodes
By IVT NetworkIn this episode, Stacey and Cliff speak about new ways of thinking across the industry that aim to ensure appropriate, risk-based, least burdensome validation, with a focus of validation activities, instead of the traditional “are we compliant” mentality.
For more information on this topic:
ICH Q10 Feedforward, https://www.fda.gov/media/71553/download
- Process Validation Systems Based Inspection, https://www.fda.gov/files/drugs/published/Process-Validation--General-Principles-and-Practices.pdf
Cliff is a highly experienced consultant with a proven track record in efficient, agile and flexible compliance. His strengths include validation strategy, process mapping and gap analysis projects, both short and long term. He is exceptionally well regarded, and has worked collaboratively and co-authored with regulatory agencies, such as the FDA and HPRA, providing leadership training and advisory services. In addition to FDA, projects and workshops have been successfully completed for the following companies: Aveo, Amgen, Bayer, BioMarin, Celgene, Janssen, Kite, Lonza, Novartis, Parexel, Pfizer, Prolong. Cliff is also a long time contributor to the IVT Network, publishing articles in the Journal of Validation
Technology since 2010. Cliff was awarded the Kenneth G. Chapman Award in 2017 in recognition for his long standing efforts and contributions to validation.
Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com.